SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-008297
Filing Date
2024-05-15
Accepted
2024-05-15 16:30:55
Documents
66
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q agrx-20240331x10q.htm   iXBRL 10-Q 1095869
2 EX-31.1 agrx-20240331xex31d1.htm EX-31.1 10620
3 EX-31.2 agrx-20240331xex31d2.htm EX-31.2 10562
4 EX-32.1 agrx-20240331xex32d1.htm EX-32.1 5935
5 EX-32.2 agrx-20240331xex32d2.htm EX-32.2 5901
  Complete submission text file 0001558370-24-008297.txt   5283472

Data Files

Seq Description Document Type Size
6 EX-101.SCH agrx-20240331.xsd EX-101.SCH 46606
7 EX-101.CAL agrx-20240331_cal.xml EX-101.CAL 41079
8 EX-101.DEF agrx-20240331_def.xml EX-101.DEF 170913
9 EX-101.LAB agrx-20240331_lab.xml EX-101.LAB 379057
10 EX-101.PRE agrx-20240331_pre.xml EX-101.PRE 276104
70 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20240331x10q_htm.xml XML 730593
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36464 | Film No.: 24951520
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)